BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Luo J. TGF-β as a Key Modulator of Astrocyte Reactivity: Disease Relevance and Therapeutic Implications. Biomedicines 2022;10:1206. [PMID: 35625943 DOI: 10.3390/biomedicines10051206] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Alonso-Alonso ML, Sampedro-Viana A, Fernández-Rodicio S, Bazarra-Barreiros M, Ouro A, Sobrino T, Campos F, Castillo J, Hervella P, Iglesias-Rey R. Need for a Paradigm Shift in the Treatment of Ischemic Stroke: The Blood-Brain Barrier. Int J Mol Sci 2022;23:9486. [PMID: 36012745 DOI: 10.3390/ijms23169486] [Reference Citation Analysis]
2 Mantia K, Kostas V, Katerina M. The promise of the TGF-β superfamily as a therapeutic target for Parkinson's disease. Neurobiol Dis 2022;:105805. [PMID: 35764291 DOI: 10.1016/j.nbd.2022.105805] [Reference Citation Analysis]